The HICCC is invested in comprehensive evaluation and planning, at the level of individual Programs, intra HICCC strategic planning, and integration of planning throughout CUMC and NYPH. Upon Dr. Emerson's arrival in 2012, the HICCC underwent an extensive strategic planning process involving every Program and Shared Resource, the Internal Advisory Committee and External Scientific Advisory Board, and additional HICCC basic, clinical/translational and population strategic planning committees. Out of this process emerged a Strategic Plan to support and expand the research programs at the HICCC, a plan that has now been endorsed by the CUMC and NYPH Leadership. To support the programmatic initiatives, the plan also calls for the broadening and reshaping of the HICCC leadership;to accomplish this goal Mary Beth Terry, PhD has been appointed Associate Director for Education, Dawn Hershman, MD, MS has been appointed Associate Director for Program Development, John Chabot, MD has been appointed Associate Director for Clinical Affairs, Cory Abate-Shen, PhD was named Associate Director for Translational Research and a national search is unden/vay for a new Associate Director for Clinical Research (and Division Chief of Medical Hematology/Oncology). The HICCC Director, in consultation with the Senior Leadership Team as well as internal and external advisory boards, has the responsibility and authority to set priorities and to develop new Programs;nominate and retain scientific leaders and members;select programs, projects and members to receive pilot funding; allocate HICCC resources;organize the clinical and clinical and translational research activities, and organize the HICCC as a whole to promote productivity and scientific interactions. The main internal advisory bodies include: i) the Senior Leadership Team;ii) the Internal Advisory Committee;iii) the Space Committee;iv) the Membership Committee;and v) the Shared Resource Committee. The External Scientific Advisory Board (ESAB), currently includes 14 members representative of the major areas of HICCC research and administration, and includes 5 Directors of NCI designated Centers. Funding in the amount of $35,000 is requested for the annual meeting of the ESAB.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA013696-40
Application #
8753125
Study Section
Subcommittee G - Education (NCI)
Project Start
1997-07-04
Project End
2019-06-30
Budget Start
2014-07-17
Budget End
2015-06-30
Support Year
40
Fiscal Year
2014
Total Cost
$49,916
Indirect Cost
$18,718
Name
Columbia University (N.Y.)
Department
Type
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Proto, Jonathan D; Doran, Amanda C; Gusarova, Galina et al. (2018) Regulatory T Cells Promote Macrophage Efferocytosis during Inflammation Resolution. Immunity 49:666-677.e6
Hernandez, Celine; Huebener, Peter; Pradere, Jean-Philippe et al. (2018) HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis. J Clin Invest 128:2436-2451
Lee, Younghyun; Pujol Canadell, Monica; Shuryak, Igor et al. (2018) Candidate protein markers for radiation biodosimetry in the hematopoietically humanized mouse model. Sci Rep 8:13557
Kraakman, Michael J; Liu, Qiongming; Postigo-Fernandez, Jorge et al. (2018) PPAR? deacetylation dissociates thiazolidinedione's metabolic benefits from its adverse effects. J Clin Invest 128:2600-2612
Cui, Xuan; Jauregui, Ruben; Park, Karen Sophia et al. (2018) Multimodal characterization of a novel mutation causing vitamin B6-responsive gyrate atrophy. Ophthalmic Genet 39:512-516
Evans, Lucy P; Newell, Elizabeth A; Mahajan, MaryAnn et al. (2018) Acute vitreoretinal trauma and inflammation after traumatic brain injury in mice. Ann Clin Transl Neurol 5:240-251
Dieck, Chelsea L; Tzoneva, Gannie; Forouhar, Farhad et al. (2018) Structure and Mechanisms of NT5C2 Mutations Driving Thiopurine Resistance in Relapsed Lymphoblastic Leukemia. Cancer Cell 34:136-147.e6
Nathan, J; Ruscitto, A; Pylawka, S et al. (2018) Fibrocartilage Stem Cells Engraft and Self-Organize into Vascularized Bone. J Dent Res 97:329-337
Kratchmarov, Radomir; Viragova, Sara; Kim, Min Jung et al. (2018) Metabolic control of cell fate bifurcations in a hematopoietic progenitor population. Immunol Cell Biol 96:863-871
Sengillo, Jesse D; Lee, Winston; Bakhoum, Mathieu F et al. (2018) CHOROIDEREMIA ASSOCIATED WITH A NOVEL SYNONYMOUS MUTATION IN GENE ENCODING REP-1. Retin Cases Brief Rep 12 Suppl 1:S67-S71

Showing the most recent 10 out of 331 publications